Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1128 of 6351
-
New drug combo aims to boost radiation success in aggressive prostate cancer
Disease control CompletedRATIONALE: Androgens can cause the growth of prostate cancer cells. Drugs, such as steroid 17alpha-monooxygenase TAK-700, when used with other hormone therapy, may lessen the amount of androgens made by the body. Radiation therapy uses high energy x rays to kill tumor cells. This…
Phase 3 • Sponsor: Radiation Therapy Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New hope for rare bleeding disorder: which drug combo works best?
Disease control CompletedCREHA project is a study comparing steroid combined with cyclophosphamide versus steroid combined with rituximab in patients with acquired haemophilia. The study will test the hypothesis that steroid combined with cyclophosphamide is more effective than steroid plus rituximab for…
Phase 3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Hope for hepatitis c relapsers: new Triple-Drug combo shows promise
Disease control CompletedThis study will evaluate the efficacy and safety of MP-424 with Peginterferon Alfa-2b and Ribavirin (RBV) in patients with genotype 2 hepatitis C, who relapsed after previous treatment.
Phase 3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New hope for myelofibrosis patients who stop responding to standard therapy
Disease control Stopped earlyPrimary Objective: \- To evaluate the efficacy of once daily dose of SAR302503 in subjects previously treated with ruxolitinib and with a current diagnosis of intermediate-1 with symptoms, Intermediate-2 or high-risk primary myelofibrosis (PMF), post-polycythemia vera myelofibro…
Phase 2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New proton therapy may reduce side effects in esophageal cancer treatment
Disease control OngoingThe goal of this clinical research study is to learn how safe and effective proton-beam therapy (PBT) may be in comparison to intensity modulated radiation therapy (IMRT) in combination with chemotherapy in patients with esophageal cancer. PBT and IMRT are both forms of radiatio…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New hope for aggressive brain tumors? drug combo tested in 158 patients
Disease control CompletedThe purpose of the study is to see whether treatment with LY2157299 on its own, LY2157299 plus lomustine therapy or lomustine plus placebo can help participants with brain cancer
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New 4-Drug cocktail aims to crush myeloma early
Disease control CompletedThe purpose of this study is to evaluate the safety and effectiveness of an investigational new drug called carfilzomib, in combination with dexamethasone in subjects with newly diagnosed multiple myeloma followed by treatment with a combination of drugs clarithromycin (Biaxin®),…
Phase 2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Could adding chemo help older breast cancer patients live longer? a major trial investigates.
Disease control CompletedThe purpose of the study is to evaluate the benefit of adjuvant chemotherapy on overall survival for elderly patients with breast cancer, in a sub group with a high risk of relapse according to Genomic Grade test.
Phase 3 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
A laser microscope may let doctors see skin lesions without cutting
Diagnosis Recruiting nowThe purpose of this pilot study is to employ multiphoton microscopy to non-invasively image in-vivo pigmented and non-pigmented human skin lesions for characterization of their morphologic and functional features.
Sponsor: University of California, Irvine • Aim: Diagnosis
Last updated Sep 02, 2026 00:00 UTC
-
New combo therapy shows promise for kids with rare lymphoma
Disease control CompletedPhase II trial to determine the efficacy of Dose Adjusted-EPOCH-Rituximab regimen in children and adolescent with primary mediastinal large B cell lymphoma in terms of event free survival.
Phase 2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Does the meningitis b vaccine last? study tests kids 4 years later
Vaccine CompletedThis study aims to estimate the vaccinal immunity four years after four doses of MenbVac in children aged 4-8 years.
Phase 3 • Sponsor: University Hospital, Rouen • Aim: Vaccine
Last updated Jun 27, 2026 13:00 UTC
-
Engineered immune cells with 'Off Switch' tested for tough leukemia
Disease control OngoingThe body has different ways of fighting infection and disease. No single way is effective at fighting cancer. This research study combines two different ways of fighting disease: antibodies and T cells. Antibodies are proteins that protect the body from disease caused by bacteria…
Phase 1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could a simple infusion during surgery protect organs and save lives?
Disease control CompletedThe purpose of this study is to evaluate whether a preventive strategy of intraoperative arterial hypotension using noradrenaline can reduce the incidence of postoperative organ failure.
Phase 4 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Vitamin a shown to protect tiny Preemies' lungs
Disease control CompletedBronchopulmonary dysplasia (BPD) remains a major complication of very low birth weight (VLBW) preterm infants. Vitamin A is essential for lung development and epithelial integrity, and deficiency has been associated with an increased risk of BPD. This study aimed to evaluate the…
Phase 3 • Sponsor: Erhan Calisici • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Can adding another drug improve MDS treatment?
Disease control OngoingThis randomized phase II/III trial studies how well azacitidine works with or without lenalidomide or vorinostat in treating patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia. Drugs used in chemotherapy, such as azacitidine, work in different …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 10, 2026 02:00 UTC
-
Could PET scans guide radiation to better fight lung cancer?
Disease control CompletedThis randomized phase II trial studies how well positron emission tomography (PET)/computed tomography (CT)-guided radiation therapy works compared to standard radiation therapy in treating patients with stage III non-small cell lung cancer. Radiation therapy uses high-energy x-r…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Balloon in the womb may save babies with rare birth defect
Disease control CompletedCongenital diaphragmatic hernia (CDH) occurs when the diaphragm fails to fully fuse and leaves a portal through which abdominal structures can migrate into the thorax. In the more severe cases, the abdominal structures remain in the thoracic cavity and compromise the development …
Sponsor: Michael A Belfort • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Could belly fat age our cells faster?
Knowledge-focused CompletedNumerous epidemiological studies clearly showed the relationship between the excessive growth of visceral adipose tissue and risk of developing insulin resistance, type 2 diabetes and other cardiovascular risk factors. However, the mechanisms contributing to the deleterious role …
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Alzheimer's drug may stop chronic pain after breast surgery
Prevention CompletedThe aim of this study is to evaluate if memantine administered during 4 weeks beginning 2 weeks before surgery induces a decrease of painful intensity 3 months after surgery, compared to placebo group.
Phase 3 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Prevention
Last updated Aug 07, 2026 00:00 UTC
-
New Pill-and-Antibody combo may replace chemo for common lymphoma
Disease control CompletedThe purpose of this study is to find out if lenalidomide when given along with rituximab can help to control the disease and also increase the length of your response (complete or partial response) compared to the standard of care rituximab chemotherapy treatment.
Phase 3 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC